Potential Probiotics for the Therapy of Metabolic Dysfunction-Associated Steatotic Liver Disease
<p id="p1">Metabolic dysfunction-associated steatotic liver disease (MASLD), a prevalent metabolic disorder globally, has presented an urgent need for effective therapeutic agents. The complex pathogenesis of MASLD and the failure of numerous clinical trials targeting this disease have prompted the...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2025
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1217839 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Potential Probiotics for the Therapy of Metabolic Dysfunction-Associated Steatotic Liver Disease
- Lifestyle Intervention of Metabolic Dysfunction-Associated Steatotic Liver Disease
- Dietary Determinants of Metabolic Syndrome: Focus on the Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Pregnancy and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Relationship with Obesity, Clinical Outcomes, and Diagnosis
- Perspective Chapter: Lifestyle Interventions for Hepatic Steatosis – Cornerstone of Management in Metabolic Dysfunction-Associated Steatotic Liver Disease
- Predicting Metabolic Dysfunction-Associated Steatotic Liver Disease using Machine Learning Methods: A Retrospective Cohort Study
- Perspective Chapter: Metabolic Dysfunction-Associated Steatotic Liver Disease as an Emerging Cardiovascular Risk Factor – Pathophysiology, Implications and Clinical Perspectives